Ollonen Paula, Lehtonen Johannes, Eskelinen Matti
Department for Social and Health Affairs, State Office in Eastern Finland, P.O. Box 1741, FIN-70101 Kuopio, Finland.
Anticancer Res. 2005 May-Jun;25(3c):2527-33.
Many case-control studies have investigated the association between anxiety, depression, the history of psychiatric symptoms and risk of breast cancer. However, findings are inconsistent, and results may be explained by the fact that most of the epidemiological data available come from retrospective case-control studies. We have conducted this case-control study with a so-called "limited prospective study design" to reduce the potential for recall bias.
This study is an extension of the Kuopio Breast Cancer Study. Women with breast symptoms were referred by physicians to the Kuopio University Hospital (Finland) and were asked to participate in this study. These subjects were interviewed and all study variables were obtained before any diagnostic procedures were carried out, so neither the investigator nor the subject knew the final diagnosis of breast symptoms at the time of the interview. The research method used was the semistructured in-depth interview method. The Montgomery-Asberg Depression rating scale (MADRS) was used to evaluate the depression of the study subjects. All study subjects were also asked to complete standardised questionnaires (Beck Depression Inventory and Spielberger Trait Inventory). The Forsen Inventory was used to evaluate the history of psychiatric symptoms of the subjects in the six years prior to admission.
Clinical examination and biopsy showed breast cancer (BC) in 34 patients, benign breast disease (BBD) in 53 patients, while 28 study subjects were healthy (HSS). The mean "Forsen-score 2-6 yrs" of the BC group was lower (9.8) than the scores of the BBD group (11.8) and the HSS group (12.5) (p = 0.4). The investigator-characterized variables, "MADRS"- and "depression"-variables correlated significantly (p-value under 0.001) with those variables reported by the study subjects, "BDT", "A-trait" and "Forsen-score". The "anxiety"-variables characterized by the investigator correlated to the "A-trait"-variable and "Forsen-score"-variable reported by the study subjects (p-value under 0.05).
Our results do not support an overall association between anxiety, depression, history of psychiatric symptoms and increased breast cancer risk. However, the exact effects of psychological factors on the various hormones relevant to the development of breast cancer are at present poorly defined.
许多病例对照研究调查了焦虑、抑郁、精神症状史与乳腺癌风险之间的关联。然而,研究结果并不一致,且这些结果可能是由于现有的大多数流行病学数据来自回顾性病例对照研究这一事实所致。我们开展了这项采用所谓“有限前瞻性研究设计”的病例对照研究,以减少回忆偏倚的可能性。
本研究是库奥皮奥乳腺癌研究的扩展。有乳腺症状的女性由医生转诊至库奥皮奥大学医院(芬兰),并被邀请参与本研究。这些受试者接受了访谈,且所有研究变量均在任何诊断程序实施之前获取,因此在访谈时研究者和受试者均不知道乳腺症状的最终诊断结果。所采用的研究方法为半结构化深入访谈法。蒙哥马利-阿斯伯格抑郁评定量表(MADRS)用于评估研究受试者的抑郁情况。所有研究受试者还被要求完成标准化问卷(贝克抑郁量表和斯皮尔伯格特质量表)。福尔森量表用于评估受试者入院前六年的精神症状史。
临床检查和活检显示,34例患者患有乳腺癌(BC),53例患者患有良性乳腺疾病(BBD),而28名研究受试者健康(HSS)。乳腺癌组的平均“福尔森评分2 - 6年”(9.8)低于良性乳腺疾病组(11.8)和健康组(12.5)(p = 0.4)。研究者界定的变量、“MADRS”变量和“抑郁”变量与研究受试者报告的变量“BDT”、“A特质”和“福尔森评分”显著相关(p值小于0.001)。研究者界定的“焦虑”变量与研究受试者报告的“A特质”变量和“福尔森评分”变量相关(p值小于0.05)。
我们的结果不支持焦虑、抑郁、精神症状史与乳腺癌风险增加之间存在总体关联。然而,目前心理因素对与乳腺癌发生相关的各种激素的确切影响尚不清楚。